IP Library Granted Patent US 8,440,236
Granted Patent B2
US 8,440,236 · App. 11/552,901 · Granted May 14, 2013

Calcium carbonate granulation

Inventors: Kevin W. Lang (Lloyd Neck, NY); James W. Dibble (Port Jefferson, NY); Raya Levin (Langhorne, PA); Gregory B. Murphy (Sands Point, NY)
Assignee: Delavau L.L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,236
App. No.
11/552,901
Granted
May 14, 2013
Kind
B2
Abstract

Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available.

Claims (20)

1. A granulation comprising free-flowing particles having sufficient cohesiveness and compactability for compression into pharmaceutical or dietary supplement tablets comprising:

i. a first powdered composition comprising a median particle diameter from about 10 to about 25 μm;

ii. a second powdered composition comprising a median particle diameter from about 0.1 to about 10 μm; and

iii. a binder,

wherein said first powdered composition comprises about 50% or more of said granulation, on a weight basis, and said second powdered composition comprises up to about 50% of said granulation, on a weight basis; and

wherein said granulation has a moisture content of less than about 1% by weight and wherein said first and second powdered compositions each comprise calcium carbonate.

2. The granulation of any of claim 1 wherein said binder comprises maltodextrin.

3. The granulation of claim 1 wherein said first powdered composition has a median particle diameter from about 12 to about 17 μm and said second powdered composition has a median particle diameter from about 1 to about 5 μm.

4. The granulation of claim 1 wherein said first powdered composition has a median particle diameter of about 15 μm and said second powdered composition has a median particle diameter of about 4 μm.

5. A granulation comprising free-flowing particles having sufficient cohesiveness and compactability for compression into pharmaceutical or dietary supplement tablets comprising:

i. a first powdered composition having a median particle diameter from about 10 to about 25 μm;

ii. second powdered composition having a median particle diameter from about 1 to about 10 μm;

iii. a third powdered composition having a median particle diameter from about 0.1 to about 1 μm; and

iv. a binder,

wherein said first powdered composition comprises about 50% or more of said granulation, on a weight basis, said second powdered composition comprises from about 10 to about 50% of said granulation, on a weight basis, and said third powdered composition comprises up to about 20% of said granulation, on a weight basis; and

wherein said granulation has a moisture content of less than about 1% by weight and wherein each of said first, second and third powdered compositions comprises calcium carbonate.

6. The granulation of claim 5 wherein said binder comprises maltodextrin.

7. The granulation of claim 5 wherein said first powdered composition has a median particle diameter from about 12 to about 17 μm; said second powdered composition has a median particle diameter from about 1 to about 5 μm; and said third powdered composition has a median particle diameter from about 0.5 to about 1 μm.

8. The granulation of claim 5 wherein said first powdered composition has a median particle diameter of about 15 μm; said second powdered composition has a median particle diameter of about 10 μm; and said third powdered composition has a median particle diameter of about 0.7 μm.

9. A pharmaceutical or dietary supplement tablet comprising the granulation of claim 1 or 5 .

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Feb 16, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: IVD, LLC
Reel/Frame 062714/0434 →
SECURITY INTEREST Recorded Feb 15, 2023
From: IVD, LLC
To: BMO HARRIS BANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 062699/0222 →
SECURITY INTEREST Recorded Mar 5, 2019
From: IVD, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 048507/0924 →
RELEASE OF SECURITY INTEREST Recorded Mar 5, 2019
From: CITIBANK, N.A.
To: INTERNATIONAL VITAMIN CORPORATION; IVP, LLC; IVD, LLC
Reel/Frame 048507/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: DELAVAU L.L.C.
To: IVD, LLC.
Reel/Frame 046935/0331 →
SECURITY INTEREST Recorded Sep 19, 2018
From: IVD, LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046909/0397 →
TERMINATION AND RELEASE OF SECURITY INTEREST Recorded Jan 23, 2012
From: DEUTSCHE BANK AG, CAYMAN ISLANDS BRANCH
To: DELAVAU L.L.C.
Reel/Frame 027576/0462 →
GRANT OF SECURITY INTEREST Recorded Sep 18, 2007
From: DELAVAU L.L.C.
To: DEUTSCHE BANK AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 019834/0645 →
Continuity (2)
Division 10631923 · Jul 31, 2003
Related Publication 20070053977A1 · Mar 8, 2007